vs
INTEST CORP（INTT）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
RECURSION PHARMACEUTICALS, INC.的季度营收约是INTEST CORP的1.1倍（$35.5M vs $32.8M），INTEST CORP净利率更高（3.8% vs -304.2%，领先308.0%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -10.3%），INTEST CORP自由现金流更多（$-1.6M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs 4.9%）
INTEST CORP是面向全球半导体产业的专业测试设备供应商，主营研发、生产及销售热管理系统、测试接口硬件、晶圆处理工具等产品，客户覆盖晶圆制造厂、芯片设计企业及汽车、工业电子等下游领域。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
INTT vs RXRX — 直观对比
营收规模更大
RXRX
是对方的1.1倍
$32.8M
营收增速更快
RXRX
高出692.1%
-10.3%
净利率更高
INTT
高出308.0%
-304.2%
自由现金流更多
INTT
多$45.8M
$-47.3M
两年增速更快
RXRX
近两年复合增速
4.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $32.8M | $35.5M |
| 净利润 | $1.2M | $-108.1M |
| 毛利率 | 45.4% | 59.8% |
| 营业利润率 | 3.9% | -304.8% |
| 净利率 | 3.8% | -304.2% |
| 营收同比 | -10.3% | 681.7% |
| 净利润同比 | -17.4% | 39.6% |
| 每股收益（稀释后） | $0.10 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收INTTRXRX
| Q4 25 | $32.8M | $35.5M | ||
| Q3 25 | $26.2M | $5.2M | ||
| Q2 25 | $28.1M | $19.2M | ||
| Q1 25 | $26.6M | $14.7M | ||
| Q4 24 | $36.6M | $4.5M | ||
| Q3 24 | $30.3M | $26.1M | ||
| Q2 24 | $34.0M | $14.4M | ||
| Q1 24 | $29.8M | $13.8M |
净利润INTTRXRX
| Q4 25 | $1.2M | $-108.1M | ||
| Q3 25 | $-938.0K | $-162.3M | ||
| Q2 25 | $-503.0K | $-171.9M | ||
| Q1 25 | $-2.3M | $-202.5M | ||
| Q4 24 | $1.5M | $-178.9M | ||
| Q3 24 | $495.0K | $-95.8M | ||
| Q2 24 | $230.0K | $-97.5M | ||
| Q1 24 | $662.0K | $-91.4M |
毛利率INTTRXRX
| Q4 25 | 45.4% | 59.8% | ||
| Q3 25 | 41.9% | -183.8% | ||
| Q2 25 | 42.6% | -4.9% | ||
| Q1 25 | 41.5% | -48.0% | ||
| Q4 24 | 39.7% | -181.4% | ||
| Q3 24 | 46.3% | 53.7% | ||
| Q2 24 | 40.6% | 36.2% | ||
| Q1 24 | 43.8% | 19.1% |
营业利润率INTTRXRX
| Q4 25 | 3.9% | -304.8% | ||
| Q3 25 | -4.5% | -3327.6% | ||
| Q2 25 | -3.3% | -916.8% | ||
| Q1 25 | -10.8% | -1297.9% | ||
| Q4 24 | 5.7% | -4042.4% | ||
| Q3 24 | 1.6% | -377.1% | ||
| Q2 24 | 1.0% | -697.4% | ||
| Q1 24 | 1.6% | -698.4% |
净利率INTTRXRX
| Q4 25 | 3.8% | -304.2% | ||
| Q3 25 | -3.6% | -3135.3% | ||
| Q2 25 | -1.8% | -894.2% | ||
| Q1 25 | -8.7% | -1373.3% | ||
| Q4 24 | 4.1% | -3935.5% | ||
| Q3 24 | 1.6% | -367.5% | ||
| Q2 24 | 0.7% | -676.6% | ||
| Q1 24 | 2.2% | -662.4% |
每股收益（稀释后）INTTRXRX
| Q4 25 | $0.10 | $-0.17 | ||
| Q3 25 | $-0.08 | $-0.36 | ||
| Q2 25 | $-0.04 | $-0.41 | ||
| Q1 25 | $-0.19 | $-0.50 | ||
| Q4 24 | $0.13 | $-0.56 | ||
| Q3 24 | $0.04 | $-0.34 | ||
| Q2 24 | $0.02 | $-0.40 | ||
| Q1 24 | $0.05 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $14.2M | $743.3M |
| 总债务越低越好 | — | $9.6M |
| 股东权益账面价值 | $103.6M | $1.1B |
| 总资产 | $151.3M | $1.5B |
| 负债/权益比越低杠杆越低 | — | 0.01× |
8季度趋势，按日历期对齐
现金及短期投资INTTRXRX
| Q4 25 | $14.2M | $743.3M | ||
| Q3 25 | $16.2M | $659.8M | ||
| Q2 25 | $19.2M | $525.1M | ||
| Q1 25 | $22.0M | $500.5M | ||
| Q4 24 | $19.8M | $594.4M | ||
| Q3 24 | $18.0M | $427.6M | ||
| Q2 24 | $20.4M | $474.3M | ||
| Q1 24 | $27.3M | $296.3M |
总债务INTTRXRX
| Q4 25 | — | $9.6M | ||
| Q3 25 | $4.9M | $11.9M | ||
| Q2 25 | $5.9M | $14.2M | ||
| Q1 25 | $6.9M | $16.4M | ||
| Q4 24 | $7.9M | $19.0M | ||
| Q3 24 | $9.0M | $20.5M | ||
| Q2 24 | $10.0M | $22.9M | ||
| Q1 24 | $11.0M | — |
股东权益INTTRXRX
| Q4 25 | $103.6M | $1.1B | ||
| Q3 25 | $101.9M | $1.0B | ||
| Q2 25 | $102.6M | $919.1M | ||
| Q1 25 | $99.4M | $933.9M | ||
| Q4 24 | $99.8M | $1.0B | ||
| Q3 24 | $100.4M | $524.6M | ||
| Q2 24 | $99.5M | $584.4M | ||
| Q1 24 | $99.3M | $401.2M |
总资产INTTRXRX
| Q4 25 | $151.3M | $1.5B | ||
| Q3 25 | $148.3M | $1.4B | ||
| Q2 25 | $149.7M | $1.3B | ||
| Q1 25 | $148.0M | $1.3B | ||
| Q4 24 | $152.3M | $1.4B | ||
| Q3 24 | $158.4M | $726.5M | ||
| Q2 24 | $160.6M | $775.9M | ||
| Q1 24 | $159.5M | $557.8M |
负债/权益比INTTRXRX
| Q4 25 | — | 0.01× | ||
| Q3 25 | 0.05× | 0.01× | ||
| Q2 25 | 0.06× | 0.02× | ||
| Q1 25 | 0.07× | 0.02× | ||
| Q4 24 | 0.08× | 0.02× | ||
| Q3 24 | 0.09× | 0.04× | ||
| Q2 24 | 0.10× | 0.04× | ||
| Q1 24 | 0.11× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-1.0M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $-1.6M | $-47.3M |
| 自由现金流率自由现金流/营收 | -4.7% | -133.1% |
| 资本支出强度资本支出/营收 | 1.6% | 3.5% |
| 现金转化率经营现金流/净利润 | -0.82× | — |
| 过去12个月自由现金流最近4个季度 | $5.7M | $-378.3M |
8季度趋势，按日历期对齐
经营现金流INTTRXRX
| Q4 25 | $-1.0M | $-46.1M | ||
| Q3 25 | $3.5M | $-117.4M | ||
| Q2 25 | $-688.0K | $-76.4M | ||
| Q1 25 | $5.5M | $-132.0M | ||
| Q4 24 | $2.6M | $-115.4M | ||
| Q3 24 | $4.2M | $-59.2M | ||
| Q2 24 | $-5.1M | $-82.2M | ||
| Q1 24 | $2.1M | $-102.3M |
自由现金流INTTRXRX
| Q4 25 | $-1.6M | $-47.3M | ||
| Q3 25 | $3.1M | $-117.6M | ||
| Q2 25 | $-1.1M | $-79.6M | ||
| Q1 25 | $5.3M | $-133.8M | ||
| Q4 24 | $2.4M | $-116.7M | ||
| Q3 24 | $3.7M | $-63.8M | ||
| Q2 24 | $-5.4M | $-83.4M | ||
| Q1 24 | $1.7M | $-109.0M |
自由现金流率INTTRXRX
| Q4 25 | -4.7% | -133.1% | ||
| Q3 25 | 11.8% | -2272.5% | ||
| Q2 25 | -4.1% | -413.9% | ||
| Q1 25 | 19.9% | -907.4% | ||
| Q4 24 | 6.6% | -2567.7% | ||
| Q3 24 | 12.4% | -244.6% | ||
| Q2 24 | -15.9% | -578.5% | ||
| Q1 24 | 5.8% | -789.9% |
资本支出强度INTTRXRX
| Q4 25 | 1.6% | 3.5% | ||
| Q3 25 | 1.6% | 4.7% | ||
| Q2 25 | 1.6% | 16.4% | ||
| Q1 25 | 0.9% | 12.4% | ||
| Q4 24 | 0.4% | 28.6% | ||
| Q3 24 | 1.7% | 17.5% | ||
| Q2 24 | 0.9% | 8.2% | ||
| Q1 24 | 1.1% | 48.2% |
现金转化率INTTRXRX
| Q4 25 | -0.82× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 1.72× | — | ||
| Q3 24 | 8.58× | — | ||
| Q2 24 | -22.13× | — | ||
| Q1 24 | 3.13× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
INTT
| Environmental Technologies | $8.3M | 25% |
| Semiconductor Market | $6.9M | 21% |
| Thermal Testing Products | $6.4M | 19% |
| Service And Other Products | $4.8M | 15% |
| Oem Integrators And Distributor | $3.5M | 11% |
| Semiconductor Production Test Products | $3.0M | 9% |
RXRX
暂无分部数据
